CClinicalTrials.gg
RecruitingNCT06801691EUthyroid2Updated Mar 3, 2025

The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe

An interventional study of Experimental: Intervention group in Iodine Deficiency, sponsored by EUthyroid. Recruiting at 6 sites in 6 countries. Open to participants aged 13 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-03.

Sponsored by EUthyroid · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
4,500
Allocation
Not applicable
Ages
13 Years to 17 Years
Sex
All
01

Study summary

In the EUthyroid2 intervention, measures are being developed and implemented in educational settings across the UK, Germany, Slovenia, the Republic of Cyprus, Bangladesh, and Pakistan to effectively raise awareness of the risks associated with iodine deficiency. Each participating country will employ three measurement points. The intervention will be tailored to the specific contextual characteristics of each implementation site. A process evaluation utilizing a convergent parallel mixed methods design will be conducted, involving surveys of students and teachers, as well as semi-structured interviews.

Read the detailed description

Detailed Description:

BACKGROUND: Iodine deficiency (ID) is a leading risk factor for thyroid disorders and developmental impairments in offspring. It is recognized as one of the most preventable causes of mental impairment in children. The EUthyroid2 project aims to contribute to the prevention of ID and its associated symptoms and disease burden in adolescents across Europe and beyond.

AIM: This project seeks to develop and implement an educational intervention in various educational settings, effectively raising awareness of the risks associated with iodine deficiency.

METHODS: The intervention will be conducted in each participating country, with three clusters (secondary schools, high schools, and vocational schools) per country. The goal is to achieve a final sample of 4500 study participants in all countries combined, involving one baseline measurement and two follow-up assessments (2-4 weeks and 6-8 months post-intervention). Data will be collected at all measurement points, with variations in implementation accounted for due to differences between countries. To ensure the intervention's functionality and effectiveness, the project will consider recommendations for developing complex interventions, appropriate theoretical frameworks, and conduct a context analysis. Outcome measures will include a newly developed iodine awareness questionnaire (primary outcome) and an iodine-specific food frequency questionnaire. Additionally, socio-demographic characteristics will be measured. Descriptive analyses will be performed on all variables, with subgroup and country-specific analyses computed. A process evaluation will assess the implementation process using a convergent parallel mixed methods design, inviting teachers and students to participate in an online questionnaire. Semi-structured interviews will further enrich this evaluation.

CONCLUSION/OUTLOOK: The results of the EUthyroid2 project may assist health authorities across participating countries in implementing effective strategies to reduce iodine deficiency and its associated risks. Ultimately, this could lead to a sustainable decrease in the disease burden induced by iodine deficiency.

02

Conditions studied

  • Iodine Deficiency

Keywords

  • Prevention
  • Iodine Deficiency
  • Intervention Study
  • Complex Intervention
  • Adaptation to context
  • Awareness
  • Iodine intake
  • Nutrition education
03

In context

Lead sponsor

This is the only study on the registry with EUthyroid as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • sufficient language skills to understand the study information, informed consent

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
4,500 participants (estimated)

Study arms

  • Experimental
    Teaching programme on iodine

    Educational materials: Iodine Feedback Tool, lecture on the topic of iodine and health, booklet, exercises, group assignments and a webpage

    Other: Experimental: Intervention group

Interventions

  • OtherExperimental: Intervention group

    Educational materials: Iodine Feedback Tool, lecture on the topic of iodine and health, booklet, exercises, group assignments and a webpage This is a pre/post intervention with no control group.

06

What researchers measure

Primary outcomes

  1. Change in awareness

    1. Change in awareness of iodine and iodine deficiency: Difference in iodine awareness is measured by an iodine awareness questionnaire. The scoring ranges from 1 to 22 points with higher scores indicating a better outcome of awareness.

    Time frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months) in students (13-17 years)

Secondary outcomes

  1. Changes between teaching modalities

    Differences in iodine awareness between students taught module A vs module A+B vs module A+C vs module A+B+C. Changes in iodine awareness are assessed by the iodine awareness questionnaire. The scoring ranges from 1 to 22 points with higher scores indicating a better outcome of awareness.

    Time frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)

  2. Changes in vocational schools, high- and secondary schools

    Differences in iodine awareness between students in vocational schools vs high schools vs secondary schools. Changes in iodine awareness are assessed by the iodine awareness questionnaire. The scoring ranges from 1 to 22 points with higher scores indicating a better outcome of awareness.

    Time frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)

  3. Change between age groups and gender distinctions

    Differences in iodine awareness between girls vs boys. Changes in iodine awareness are assessed by the iodine awareness questionnaire. Differences in iodine awareness between 13-year-olds vs 14-year-olds vs 15-year-olds vs 16-year-olds vs 17-year-olds. Changes in iodine awareness are assessed by the iodine awareness questionnaire. The scoring ranges from 1 to 22 points with higher scores indicating a better outcome of awareness. Gender and age will be self-reported in a socio-demographic questionnaire.

    Time frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)

  4. Change in iodine intake

    Dietary iodine intake is assessed through a food frequency questionnaire (FFQ), covering five main categories (cow's milk, fish, eggs, supplements, and salt) and regional components in each country. Each category is scored based on frequency (portions per day, week, or month), and individual sources are analyzed for iodine intake. For example, taking supplements 5-7 times a week or consuming a combination of multiple sources of cow's milk, fish and eggs a week may suggest sufficient intake. Regional differences are also considered, as salt is an iodine source in countries like Pakistan and Bangladesh, but not in the UK or Norway. The number of iodine sources will be compared before and after the intervention within each country, with a higher number of sources indicating a higher iodine intake). The number will differ according to the number of sources in each country.

    Time frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)

07

Study locations

6 of 6 sites recruiting
  • Bangladesh University of Health
    Dhaka, 1216, Bangladesh
    Recruiting
  • Cyprus University of Technology
    Limassol, 3041, Cyprus
    Recruiting
  • University Medicine Greifswald
    Greifswald, 17475, Germany
    Recruiting
  • Islamia College Peshawar
    Peshawar, Khyber Pakhtunkhwa, Pakistan
    Recruiting
  • University Medical Centre Ljubljana
    Ljubljana, 1000, Slovenia
    Recruiting
  • University of Surrey; Queen's University Belfast
    Guildford, GU2 7XH, United Kingdom
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06801691
Lead sponsor
EUthyroid
Collaborators
EU Horizon, UK Research and Innovation
Responsible party
Sponsor
First posted
Jan 30, 2025
Start date
Dec 30, 2024
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Mar 3, 2025

Study contacts

Henry Völzke
Contact
henry.voelzke@med.uni-greifswald.de
0049 3834 86 75 41

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion